Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 14 EP applications Estelle Bouron has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 17, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13170242

Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or in the prevention of atrial fibrillation

IPC classification:
A61K 31/343, A61P 9/04
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Agent:
Estelle Bouron, Sanofi, S.A.
Status:
EXAMINATION IN PROGRESS
EP12711858

BENZOIC ACID SALT OF OTAMIXABAN

IPC classification:
A61K 31/44, C07D 213/16, A61P 9/00
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Agent:
Estelle Bouron, Sanofi, S.A.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12710516

OTAMIXABAN FORMULATIONS WITH IMPROVED STABILITY

IPC classification:
A61K 47/12, A61K 31/4418, A61K 9/00, A61P 7/02
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Agent:
Estelle Bouron, Sanofi, S.A.
Status:
GRANT OF PATENT INTENDED
EP12733700

PHARMACEUTICAL COMPOSITION AND SOLID GALENIC FORM HAVING A HIGH DRONEDARONE CONTENT, AND METHOD FOR PREPARING SAME

IPC classification:
A61K 47/32, A61K 47/30, A61K 47/12, A61K 47/10, A61K 47/02, A61K 31/343, A61K 9/20, A61P 9/06
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Agent:
Estelle Bouron, Sanofi, S.A.
Status:
EXAMINATION REQUESTED
EP12731504

DRONEDARONE FOR THE PREVENTION OF ATRIAL FIBRILLATION

IPC classification:
A61K 31/343, A61P 9/04
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Agent:
Estelle Bouron, Sanofi, S.A.
Status:
GRANT OF PATENT INTENDED
EP11757603

DERIVATIVES OF N-[(1H-PYRAZOL-1-YL)ARYL]-1H-INDOLE OR 1H-INDAZOLE-3-CARBOXAMIDE, THEIR PREPARATION AND THEIR USE AS P2Y12 ANTAGONISTS

IPC classification:
A61K 31/506, A61K 31/501, A61K 31/497, A61K 31/455, A61K 31/439, C07D 487/08, C07D 487/04, C07D 471/08, C07D 471/04, C07D 413/14, C07D 409/14, C07D 405/14, C07D 403/14, C07D 403/12, C07D 401/14, A61P 9/00
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12717364

PROCESS FOR SYNTHESIZING KETO-BENZOFURAN DERIVATIVES

IPC classification:
C07D 307/84, C07D 307/80, C07C 311/21, C07C 311/08
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Agent:
Estelle Bouron, Sanofi, S.A.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12717365

METHOD FOR SYNTHESIZING KETOBENZOFURAN DERIVATIVES

IPC classification:
C07D 307/84, C07D 307/80
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Agent:
Estelle Bouron, Sanofi, S.A.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12306334

Derivatives of 1H-indole-3-carboxamide and their use as P2Y12 antagonists

IPC classification:
A61K 31/501, C07D 403/12, C07D 401/14, A61P 37/00, A61P 29/00, A61P 7/00
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Agent:
Estelle Bouron, Sanofi, S.A.
Status:
APPLICATION REFUSED
EP13305008

Compositions and methods using hdm2 antagonist and mek inhibitor

IPC classification:
A61K 31/455, A61K 31/44, A61K 31/404, A61P 35/00
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Agent:
Estelle Bouron, Sanofi, S.A.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13725136

DRONEDARONE FOR USE IN LEISHMANIASIS, FORMULATIONS AND ASSOCIATIONS FOR USE IN LEISHMANIASIS.

IPC classification:
A61K 31/343, A61P 33/02
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Agent:
Estelle Bouron, Sanofi, S.A.
Status:
GRANT OF PATENT INTENDED
EP13737259

USE OF VEGFR-3 INHIBITORS FOR TREATING HEPATOCELLULAR CARCINOMA

IPC classification:
A61K 31/4375, A61P 35/00
Applicant:
Sanofi, S.A.
Agent:
Pascale A.M.P. Le Coupanec, Cabinet Nony
Agent:
Estelle Bouron, Sanofi
Agent:
Estelle Bouron, Sanofi, S.A.
Status:
PATENT GRANTED
EP13758812

OTAMIXABAN FOR USE IN THE TREATMENT OF NON-ST ELEVATION ACUTE CORONARY SYNDROME IN PATIENTS PLANNED TO UNDERGO CORONARY ARTERY BYPASS GRAFTING

IPC classification:
A61K 31/4409, A61P 9/10
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
EXAMINATION IN PROGRESS
EP17155797

USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR IN THE PREVENTION OF ATRIAL FIBRILLATION

IPC classification:
A61P 9/04, A61K 31/343
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
Request for examination was made

Please Sign in to use this feature